Abstract. An influenza virus, A/equine/Alaska/1/91 (H3N8), was isolated from horses from Alaska with an acute respiratory infection. Pathogenic and serologic studies revealed that this virus is similar to previously isolated equine H3N8 influenza viruses. Antigenic analyses utilizing hemagglutination inhibition and neuraminidase inhibition assays indicated an antigenic drift from the prototype equine H3N8 influenza virus, A/equine/Miami/1/63. Partial sequence analysis of the A/equine/Alaska influenza virus indicated that each of 8 gene sequences are of equine origin.
An influenza virus was isolated from nasal swabs and lung tissues from an equine submission from Alaska at the National Veterinary Services Laboratories (NVSL), Ames, Iowa. The clinical signs were referable to an upper respiratory infection, and the outbreak of the disease was described by the submitting veterinarian as "explosive." An entire group of 51 animals was involved, and I animal died. The influenza virus isolated was identified as an H3N8 virus. Because of the high morbidity of this outbreak of equine influenza, there was concern that the virus might be related to the H3N8 influenza virus that caused high morbidity with mortality in horses in the People's Republic of China in 1989. 9 Pathogenic studies were initiated to compare this virus with previously isolated H3N8 influenza viruses. Antigen and sequence homology studies were conducted to determine the relatedness of the A/equine/Alaska virus to influenza viruses isolated from different geographic regions and species.
Materials and methods

Virus.
A/equine/Alaska/1/91 was isolated from equine nasal swabs and lung tissue on the second passage in lo-dayold embryonati ng chicken eggs. One additional egg passage wasrequired to obtain inoculum pools of sufficient titer with to be 106.26/ml egg-infectious (EID 50 ) units. Two 6-monthold Welsh/Shetland pony foals, negative for antibody to equine influenza, were infected with undiluted amniotic fluid by nebulization into the nares. One foal (no. 1S) was nebulized with 2 ml and the other (no. 1B) with 4 ml of amniotic fluid.
Sampling procedures and virus isolation. The foals were observed daily for clinical signs, and rectal temperatures were taken daily. Serum samples were collected on postinfection (PI) days 7, 9, 15, and 21 for serologic tests. Nasal samples on cotton swabs and blood samples in heparin were collected on PI days 3, 5, 7, 9, and 15 for virus isolation. The swabs were placed in brain-heart infusion broth and stored at -70 C. Attempts at virus isolation were made in 10-day-old embryonating chicken eggs.
7 Blood samples were collected for hematologic studies prior to infection and on PI days 2, 3, 4, 7, 9, 11, 15, and 20. Significant hematologic changes were not noted, so data were not included.
Serologic tests. Hemagglutination titration and hemagglutination inhibition (HI) tests were performed in microtiter plates with receptor-destroying enzyme a -treated sera. 8 Neuraminidase titration and neuraminidase inhibition (NI) tests were performed as described.* Antisera and specific antibodies. Antisera to the equine strains were prepared in ferrets as described previously. 5 Antisera specific for the isolated hemagglutination and neuraminidase antigens of the reference viruses were prepared in goats. Sequencing. Ribonucleic acid (RNA) was extracted by respiratory viruses was confirmed by incubation of the in-treatment of purified virus with proteinase K and sodium oculum with rabbit kidney-13 cells and equine dermal cells. dodecyl sulfate followed by the use of phenol-chloroform (1:
Infection method. The infectivity of the virus was deter-1) and ethanol precipitation. 3 Nucleotide sequences were demined by titration in lo-day-old embryonating chicken eggs termined through direct RNA sequencing by the dideoxynucleotide chain termination method 1 using purified viral RNA signs of influenza occurred with the higher dose of virus 8 Table 1 . Clinical, virologic, and serologic responses following intranasal exposure of foals to A/equine/Alaska/1/91.
(foal 1B), although infection was established in both animals as demonstrated by virus isolation and antibody response ( Table 1 ). The threshold dosage of virus required to produce clinical signs approximated dosages previously described for equine H3N8 influenza viruses 6 which suggests that the pathogenicity of A/equine/Alaska is similar to that of previously isolated H3N8 influenza viruses.
Antigenic relationships of equine influenza virus from different geographic regions. Antigenic analysis of in-
fluenza virus isolated from horses in different geographic regions was done to establish their interrelationships. Hemagglutination inhibition assays with postinfection ferret sera indicates that the A/equine/ Alaska influenza virus is inhibited by antisera to equine H3N8 influenza viruses (Table 2 ). Antiserum to A/equine/Alaska was produced in a ferret and reacted to higher titers with the homologous virus than with other equine influenza viruses isolated in the continental USA or with the isolate from the People's Republic of China (A/equine/Jilin/1/89). This serum did not react at all with prototype equine H3N8 virus (A/ equine/Miami/1/63) and avian H3N8 viruses. These results suggest that the A/equine/Alaska isolate is antigenically related to recent equine influenza virus isolates from the continental USA, but it has undergone a significant antigenic drift from the prototype equine H3N8 virus, A/equine/Miami/1/63. Neuraminidase inhibition. Hyperimmune monospecific goat antiserum showed that the neuraminidase on the A/equine/Alaska isolate was of the N8 subtype (Table 3 ). Rabbit antiserum inhibited the A/equine/ Alaska isolate at lower titers than did isolates from horses in the USA isolated in the past 10 years, suggesting that the neuraminidase of this isolate has drifted antigenically.
Sequence homology between A/equine/Alaska/1/91 (H3N8) and influenza A viruses from different species and geographic regions.
The above studies provide information on the antigenic reactivity of only 2 of the 8 gene products of the A/equine/Alaska influenza virus. To determine if all the genes of A/equine/Alaska virus were related to equine influenza viruses and to determine the extent of the relationship, partial sequencing was done on each gene segment (Table 4 ). All 8 genes of the A/equine/Alaska isolate are related to equine influenza virus isolates. The extent of homology varied from a low of 95.8% for the PA gene to a high of 99.6% for the M gene. The homology between A/equine/Alaska and the equine influenza isolate from the People's Republic of China (A/equine/ Jilin/1/89) was no higher than with human, swine, or avian strains.
The partial sequence analysis indicates that each of Table 3 . Cross-reactivity (titers) between A/equine/Alaska/1/91 and other H3N8 influenza viruses in neuraminidase inhibiting assays.
the 8 gene segments in the A/equine/Alaska influenza the emergence of strains with higher pathogenicity, as virus are of equine origin and are most closely related was experienced in China in 1989. to equine strains isolated over the past 10 years from horses in the continental USA. 
